Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane
Bayer announced the submission of a marketing authorization application to the European Medicines Agency for its investigational contrast agent gadoquatrane for contrast enhancement in magnetic resonance imaging to detect and visualize known or suspected …